EUVIMEDEUVIMED entdecken
Crossref

In Situ Gene Engineering Approach to Overcome Tumor Resistance and Enhance T Cell-Mediated Cancer Immunotherapy

Di Zhang iD, Wenjuan Wang, Mingtan Tang, Chenghao Qu, Zeyu Jiang, Xuerui Li, Yuxia Luan iD

Nano Letters · 2025

DOI: 10.1021/acs.nanolett.5c00488 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, 2025. Verfasst von Di Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Chemical Biology (Ministry of Education), Shandong Key Laboratory of Targeted Drug Delivery and Advanced Pharmaceutics, NMPA Key La…. Hauptthemen laut MEDLINE: T-Lymphocytes, Cytotoxic, Immunotherapy, Gene Editing, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, CytotoxicImmunotherapyGene EditingNeoplasmsAnimalsInterleukin-12CRISPR-Cas SystemsMiceHumansCell Line, TumorTumor MicroenvironmentDendrimersEndosomal Sorting Complexes Required for TransportGenetic Engineering

Stichwörter der Autor:innen

CRISPR/Cas9cancer immunotherapygene engineeringgranzymenanomedicine

Substanzen

Interleukin-12DendrimersEndosomal Sorting Complexes Required for Transport

Autor:innen und Institutionen

  • Key Laboratory of Chemical Biology (Ministry of Education), Shandong Key Laboratory of Targeted Drug Delivery and Advanced Pharmaceutics, NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, Scho…
  • Department of Thoracic Surgery, Qilu Hospital of Shandong University, 107 West Wenhua Road, Jinan, 250012, China.

ORCID-Profile: Di Zhang, Yuxia Luan

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, D., Wang, W., Tang, M., Qu, C., Jiang, Z., Li, X., & Luan, Y. (2025). In Situ Gene Engineering Approach to Overcome Tumor Resistance and Enhance T Cell-Mediated Cancer Immunotherapy. Nano Letters. https://doi.org/10.1021/acs.nanolett.5c00488

Vancouver

Zhang D, Wang W, Tang M, Qu C, Jiang Z, Li X, et al. In Situ Gene Engineering Approach to Overcome Tumor Resistance and Enhance T Cell-Mediated Cancer Immunotherapy. Nano Letters. 2025. doi:10.1021/acs.nanolett.5c00488

BibTeX
@article{Zhang2025,
  author = {Zhang, Di and Wang, Wenjuan and Tang, Mingtan and Qu, Chenghao and Jiang, Zeyu and Li, Xuerui and Luan, Yuxia},
  title = {In Situ Gene Engineering Approach to Overcome Tumor Resistance and Enhance T Cell-Mediated Cancer Immunotherapy},
  journal = {Nano Letters},
  year = {2025},
  doi = {10.1021/acs.nanolett.5c00488}
}
Kostenlos starten →